TITLE

Be haunted not by the "Ghost of Christmas Future": Hunt for albuminuria and treating it effectively

AUTHOR(S)
Patel, Vinod
PUB. DATE
December 2013
SOURCE
Diabetes Digest;2013, Vol. 12 Issue 4, p210
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a study on the association between cardiovascular (CV) risk factor and albuminuria in individuals with type 2 diabetes (T2D) and type 1 diabetes (T1D) in Belgium. The study shows that albuminuria was related to an increased risk in CV, more frequent antihypertensive treatment, smoking and longer diabetes duration. It revealed that albuminuria was related to diabetic complications and CV risk factors in individuals with T2D and T1D.
ACCESSION #
93451123

 

Related Articles

  • Pregnancy and diabetic nephropathy. Bilous, Rudy // Diabetes Digest;2014, Vol. 13 Issue 1, p34 

    The article investigates the prevalence of diabetic nephropathy (DN) in pregnant women with diabetes as these women are prone to pre-eclampsia, and of having both small- and large-for-gestational-age foetuses, with a higher risk of congenital malformation. It suggests that pregnant women with DN...

  • Diabetes and Cardiovascular Risk: Are Dipeptidyl Peptidase-4 Inhibitors Beneficial? Howard, Patricia A. // Hospital Pharmacy;Sep2014, Vol. 49 Issue 8, p697 

    Cardiovascular (CV) disease is a major cause of morbidity and mortality in patients with diabetes. Whereas the link between glycemic control and reducing microvascular disease is firmly established, the evidence for macrovascular risk reduction remains unclear. Despite a host of available drugs...

  • UAE screening has prognostic value in people with T2D.  // Diabetes Digest;2012, Vol. 11 Issue 3, p174 

    The article reflects on research conducted to examine the relationship between the change in UAE over 1 year and 10 year cardiovascular (CV) mortality in people with T2D and hypertension and reveals that UAE screening in such people has good prognostic value and should continue.

  • A multi-pronged approach: A new strategy for improving cardiovascular risk factors? Vora, Jiten // Diabetes Digest;2013, Vol. 12 Issue 4, p206 

    The article presents a study which aims to assess the control of blood lipids, blood pressure (BP) and blood glucose among people with type 2 diabetes (T2D) as cardiovascular disease (CVD) risk factor. The study reveals that just 5.6% of participants attained all three target goals. It shows...

  • Different prevalence of metabolic control and chronic complication rate according to the time of referral to a diabetes care unit in the elderly. Strollo, Felice; Guarino, Giuseppina; Marino, Giampiero; Paolisso, Giuseppe; Gentile, Sandro // Acta Diabetologica;Jun2014, Vol. 51 Issue 3, p447 

    The time of diagnosis is crucial for type 2 diabetes mellitus (T2DM) in terms of disease severity and chronic complications, as initial glycated haemoglobin (HbA1c) predicts 5-year cardiovascular mortality. The Italian health-care system relies on about 650 diabetes care units (DCU) interfacing...

  • Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats. Zhai, Limin; Gu, Junfei; Yang, Di; Wang, Wei; Ye, Shandong // Journal of Diabetes Research;5/13/2015, Vol. 2015, p1 

    Podocalyxin (PCX) is a signature molecule of the glomerular podocyte and of maintaining integrity of filtration function of glomerulus. The aim of this study was to observe the effect of different doses of metformin on renal tissue PCX expression in type 2 diabetic rats and clarify its...

  • Adverse Effects Associated with the Use of Antihypertensive Drugs: An Overview. Joshi, Vishal D.; Dahake, Akash P.; Suthar, Ashok P. // International Journal of PharmTech Research;Jan-Mar2010, Vol. 2 Issue 1, p10 

    Hypertension is one of the most important cardiovascular risk factor but its control is still Challenge for physicians all around the world. Antihypertensive are a class of drugs that are used in medicine and pharmacology to treat hypertension (high blood pressure). All Hypertensive drugs cause...

  • Diagnostic Value of the Combined Measurement of Serum Hcy, Serum Cys C, and Urinary Microalbumin in Type 2 Diabetes Mellitus with Early Complicating Diabetic Nephropathy. Tengkai Wang; Qian Wang; Zhimei Wang; Zuomin Xiao; Lunqin Liu // ISRN Endocrinology;2013, p1 

    Diabetic nephropathy (DN) is a major cause of end-stage kidney disease, and therefore early diagnosis and intervention may help reverse renal damage. One hundred and sixty-eight patients with T2DM and 56 healthy volunteers (control group) were enrolled at Shandong University Qilu Hospital...

  • Laboratory Assessment of Diabetic Kidney Disease. Narva, Andrew S.; Bilous, Rudolf W. // Diabetes Spectrum;Summer2015, Vol. 28 Issue 3, p162 

    The article discusses importance of understanding the laboratory tests conducted to determine the estimated glomerular filtration rate (eGFR) and albumin excretion levels in urine for the treatment of patients with diabetic kidney disease (DKD). Topics discussed includes easy passage for albumin...

  • Improved Outcomes with Antihypertensive Medication in the Elderly with Isolated Systolic Hypertension. Wang, J-G.; Staessen, J.A. // Drugs & Aging;2001, Vol. 18 Issue 5, p345 

    Isolated systolic hypertension affects over 15% of all individuals aged >60 years. In the elderly, systolic hypertension is a major modifiable cardiovascular risk factor. Systolic blood pressure (SBP) is associated with higher risk of an adverse outcome, whereas diastolic blood pressure (DBP) is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics